Skip to content

CLSXTradr 2X Long CLSK Daily ETF

Take a betNewRanked #475 of 949 in this goal

Seeks daily investment results that correspond to 200% of the daily performance of CleanSpark, Inc.

By AXS · Launched 2025

Annual Cost

1.30%

#5,565 of 5,861 · expensive

Fund Size

$22M

#4,396 of 5,861 · small

Return (1Y)Goal

N/A

Track Record

11 months

#4,635 of 5,861 · young

Performance

Total-return NAV · USD
Growth of $10,000
$5,250-47.5%

Total-return NAV, USD. Net of fund fees, before tax.

What's inside

How Beacon categorizes this fund

Asset class

Equity

Strategy

Leveraged

What it actually holds

By weight

Concentration

single-stock bet — holdings shown are derivatives collateral, not diversification

CFD CLEANSPARK INC
2.9%
CFD CLEANSPARK INC
-0.3%

Asset allocation

Stocks
63.6%
Cash
36.4%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years
Volatility (1Y)
N/A
Max drawdown
-93.2%Severe

Worst peak-to-trough loss

Sharpe (3Y)
Unavailable

Needs 3+ years of history

Sortino (3Y)
Not yet

Needs 3+ years of history

Listing

Exchange
Cboe BZX

Full fund details

Objective
Seeks daily investment results that correspond to 200% of the daily performance of CleanSpark, Inc.
Strategy
Actively manages a portfolio to achieve 200% daily exposure to CleanSpark, Inc. through swaps and options, maintaining at least 80% exposure to CLSK. Concentrated in the Finance Services industry, with investments primarily in CLSK and related financial instruments.
Inception date
September 15, 2025
Fund family
AXS

Our take

Structural notes on how this fund behaves. Read our guide on the 6 warning signs.

Leveraged single stock
Critical

Most of these lose money

These funds amplify one stock's daily move, then reset every day. More than half of them have lost money outright, and the daily reset plus financing costs drag roughly 9.5% a year off the return. The longer you hold, the more that compounding works against you.

Sources: Bessembinder, 'Leveraged Single-Stock ETFs' (SSRN 2025)

Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More

What's next?

You've looked at CLSX. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.

Data updated on 2026-08-04